These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38305400)
1. Development and Validation of Anoiki-Related Lncrna Signature Prediction Model for KIRC Prognosis. Su Y; Yang J Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38305400 [TBL] [Abstract][Full Text] [Related]
2. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma. Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X Front Immunol; 2022; 13():934387. PubMed ID: 35958561 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma. Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432 [TBL] [Abstract][Full Text] [Related]
4. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma. Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M Front Oncol; 2021; 11():663263. PubMed ID: 34123820 [TBL] [Abstract][Full Text] [Related]
5. Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation. Zhang X; Qin X; Yu T; Wang K; Chen Y; Xing Q Front Genet; 2022; 13():974726. PubMed ID: 36338996 [No Abstract] [Full Text] [Related]
6. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma. Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983 [TBL] [Abstract][Full Text] [Related]
7. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role. Zhong S; Chen S; Lin H; Luo Y; He J BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670 [TBL] [Abstract][Full Text] [Related]
8. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
9. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma. Zhu J; Zhao W; Yang J; Liu C; Wang Y; Zhao H Anticancer Drugs; 2024 Jun; 35(5):466-480. PubMed ID: 38507233 [TBL] [Abstract][Full Text] [Related]
10. Identification of autophagy-related long non-coding RNA prognostic and immune signature for clear cell renal cell carcinoma. Cui Y; Zhang S; Miao C; Liang C; Chen X; Yan T; Bu H; Dong H; Li J; Li J; Wang Z; Liu B Transl Androl Urol; 2021 Aug; 10(8):3317-3331. PubMed ID: 34532256 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma. Hong P; Huang W; Du H; Hu D; Cao Q; Wang Y; Zhang H; Tong S; Li Z; Tong M Front Genet; 2022; 13():1009555. PubMed ID: 36406128 [No Abstract] [Full Text] [Related]
12. Identification of a lactate metabolism-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma. Xu T; Liu Y; Ning B; Luo M; Wei Y Transl Androl Urol; 2024 Apr; 13(4):509-525. PubMed ID: 38721281 [TBL] [Abstract][Full Text] [Related]
13. Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma. Gao Y; Jia Z Genet Res (Camb); 2022; 2022():6004852. PubMed ID: 36474620 [TBL] [Abstract][Full Text] [Related]
14. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma. Zhou L; Fang H; Guo F; Yin M; Long H; Weng G J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis. Li D; Wu X; Song W; Cheng C; Hao L; Zhang W Ann Transl Med; 2022 Nov; 10(22):1235. PubMed ID: 36544675 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy. Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P Front Oncol; 2022; 12():1024956. PubMed ID: 36439501 [TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of a competing endogenous RNA network reveals a ferroptosis-related 6-lncRNA prognostic signature in clear cell renal cell carcinoma. Zheng Q; Gong Z; Lin S; Ou D; Lin W; Shen P Adv Clin Exp Med; 2024 Dec; 33(12):1391-1407. PubMed ID: 38470002 [TBL] [Abstract][Full Text] [Related]
18. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma. Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma. Wu Q; Sun Y; Qin X; Li M; Huang S; Wang X; Weng G Front Oncol; 2023; 13():1211103. PubMed ID: 37965453 [TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a novel prognostic model using the cellular senescence-associated long non-coding RNA in gastric cancer: a biological analysis. Wang G; Mao Z; Zhou X; Zou Y; Zhao M J Gastrointest Oncol; 2022 Aug; 13(4):1640-1655. PubMed ID: 36092333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]